251,525 Shares in LifeStance Health Group, Inc. $LFST Purchased by Inspire Investing LLC

Posted by Brian Himes on Jul 1st, 2026

Inspire Investing LLC acquired a new position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) during the 1st quarter, Holdings Channel reports. The fund acquired 251,525 shares of the company’s stock, valued at approximately $1,602,000.

A number of other large investors have also recently added to or reduced their stakes in the business. Larson Financial Group LLC increased its holdings in LifeStance Health Group by 19,952.6% during the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after acquiring an additional 3,791 shares in the last quarter. Bayesian Capital Management LP purchased a new stake in shares of LifeStance Health Group in the second quarter valued at about $52,000. Krane Funds Advisors LLC purchased a new stake in shares of LifeStance Health Group in the fourth quarter valued at about $71,000. Cibc World Markets Corp acquired a new stake in shares of LifeStance Health Group in the fourth quarter valued at approximately $77,000. Finally, CIBC Bancorp USA Inc. purchased a new position in shares of LifeStance Health Group during the 3rd quarter worth approximately $78,000. 85.50% of the stock is owned by institutional investors and hedge funds.

LifeStance Health Group Stock Performance

Shares of NASDAQ LFST opened at $10.74 on Wednesday. The company has a 50-day simple moving average of $8.06 and a 200-day simple moving average of $7.31. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.48 and a quick ratio of 1.48. The company has a market cap of $4.17 billion, a PE ratio of 179.07 and a beta of 1.19. LifeStance Health Group, Inc. has a 12 month low of $3.74 and a 12 month high of $10.89.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.03. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The business had revenue of $403.48 million for the quarter, compared to the consensus estimate of $387.46 million. The business’s revenue was up 21.2% compared to the same quarter last year. On average, equities analysts anticipate that LifeStance Health Group, Inc. will post 0.12 earnings per share for the current year.

Analysts Set New Price Targets

LFST has been the subject of several research reports. Barclays lifted their price objective on LifeStance Health Group from $8.00 to $9.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of LifeStance Health Group in a research report on Wednesday, May 27th. JPMorgan Chase & Co. boosted their price target on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Thursday, May 14th. Jefferies Financial Group raised LifeStance Health Group to a “strong-buy” rating in a report on Thursday, March 12th. Finally, BTIG Research increased their price objective on LifeStance Health Group from $11.00 to $12.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Two analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $9.75.

View Our Latest Research Report on LFST

Insider Buying and Selling at LifeStance Health Group

In other news, Director Robert Bessler sold 894,337 shares of LifeStance Health Group stock in a transaction on Friday, June 26th. The stock was sold at an average price of $10.13, for a total value of $9,059,633.81. Following the completion of the sale, the director owned 539,763 shares of the company’s stock, valued at $5,467,799.19. The trade was a 62.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Eric Shuey sold 243,362 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total value of $1,951,763.24. Following the completion of the transaction, the director owned 867,562 shares of the company’s stock, valued at $6,957,847.24. The trade was a 21.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 7,762,394 shares of company stock worth $64,107,859. Insiders own 6.60% of the company’s stock.

About LifeStance Health Group

(Free Report)

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.